THERACAP131, Iodure(131I) de sodium per thérapie, hard capsule capsule
Active ingredients: Sodium iodide i-131
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Hard capsulecapsuleorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- THERACAP131, Iodure(131I) de sodium pour thérapie, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- flacon(s) polycarbonate de 1 gélule(s)
- Marketing authorisation holder
- GE HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 20 Dec 2024
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69279253CIP75714951CIP133400957149512Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IODURE (131I) DE SODIUMgélule | 50 à 5500 MBq à la date de calibration · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.